Regeneron Pharmaceuticals, Inc. (REGN): Cash & Equivalents
$3.12B
As of 2025-12-31
$2.46B
As of 2026-06-30
+0.1%
3-year compound annual growth
+7.3%
5-year compound annual growth
+14.4%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $3.12B | +25.3% | 2026-02-04, Balance as of period end |
| 2024-12-31 | $2.49B | -8.9% | 2026-02-04, Balance as of period end |
| 2023-12-31 | $2.73B | -12.1% | 2026-02-04, Balance as of period end |
| 2022-12-31 | $3.11B | +7.6% | 2025-02-05, Balance as of period end |
| 2021-12-31 | $2.89B | +31.5% | 2024-02-05, Balance as of period end |
| 2020-12-31 | $2.19B | +35.6% | 2023-02-06, Balance as of period end |
| 2019-12-31 | $1.62B | +10.2% | 2022-02-07, Balance as of period end |
| 2018-12-31 | $1.47B | +80.6% | 2021-02-08, Balance as of period end |
| 2017-12-31 | $812.70M | +51.8% | 2020-02-07, Balance as of period end |
| 2016-12-31 | $535.20M | -33.9% | 2019-02-07, Balance as of period end |
| 2015-12-31 | $809.10M | +24.7% | 2018-02-08, Balance as of period end |
| 2014-12-31 | $648.72M | +21.1% | 2017-02-09, Balance as of period end |
| 2013-12-31 | $535.61M | +132.6% | 2016-02-11, Balance as of period end |
| 2012-12-31 | $230.28M | -52.4% | 2015-02-12, Balance as of period end |
| 2011-12-31 | $483.61M | +329.6% | 2014-02-13, Balance as of period end |
| 2010-12-31 | $112.57M | -45.6% | 2013-02-15, Balance as of period end |
| 2009-12-31 | $207.07M | -16.4% | 2012-02-21, Balance as of period end |
| 2008-12-31 | $247.80M | n/a | 2011-02-17, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $3.12B | +25.3% |
| Viatris Inc (VTRS) | 2025-12-31 | $1.32B | +80.0% |
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $5.08B | +11.3% |
| Teva Pharmaceutical Industries Ltd (TEVA) | 2025-12-31 | $3.56B | +7.8% |
| Bausch Health Companies Inc. (BHC) | 2025-12-31 | $1.31B | +10.8% |
| Organon & Co. (OGN) | 2025-12-31 | $574.00M | -15.0% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $4.55B | +73.1% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $545.00M | +16.5% |
| Abbott Laboratories (ABT) | 2025-12-31 | $8.52B | +11.9% |
Compare REGN, VTRS, VRTX, TEVA side by side · Screen every company in Pharmaceutical Preparations ↗